Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, December 03, 2018
McKesson announced the relocation of its corporate headquarters from San Francisco, California to Las Colinas, Texas, effective April 1, 2019, expanding upon its presence in the Dallas area.
read more
Friday, December 23, 2016
McKesson Corporation, a global healthcare services and information technology company, and Change Healthcare Holdings, Inc., a provider of software and analytics, network solutions and technology-enabled services, have announced that the companies ...
read more
Wednesday, August 10, 2016
Concluding a national search, industry veteran Tim McGrath has been named as the new vice president of Drug Development for Southern Research.
read more
Thursday, November 05, 2020
Monaghan Medical Corporation (MMC) announced the opening of a new 65,000-square-foot facility that doubles the size of its previous headquarters building.
read more
Thursday, November 02, 2017
The companies’ collaboration will support the adoption of MC10’s proprietary technology for use by LabCorp’s Covance Drug Development business in clinical trials and research studies.
read more
Mayne Pharma and Metrics Contract Services, have designated their new stability storage facility a “Center of Excellence.”
read more
Tuesday, February 18, 2014
Mayne Pharma USA has begun expanding its North American product portfolio by acquiring well-known branded pharmaceuticals used to treat pain.
read more
Wednesday, December 28, 2016
Mayne Pharma recently announced the U.S. launch of temozolomide capsules, 5mg, 20mg, 100mg, 140mg, 180mg and 250mg, which is a generic version of branded Temodar®.
read more
Wednesday, January 11, 2017
Mayne Pharma has announced the launch of Fabior® (tazarotene) Foam, 0.1% and Sorilux® (calcipotriene) Foam, 0.005% in the United States by Mayne Pharma’s Specialty Brands division.
read more
Mayne Pharma has entered into a long-term exclusive license and supply agreement with Mithra Pharmaceuticals SA (Mithra) for Myring®, an intravaginal hormonal contraceptive delivery device.
read more
Mayne Pharma has appointed Kimberly McClintock as executive vice president at Metrics Contract Services.
read more
Mayne Pharma Inc., has announced that the U.S. Food and Drug Administration (FDA) has granted approval of its Abbreviated New Drug Application (ANDA) for doxycycline hyclate immediate release (IR) tablets (75 mg and 150 mg). Mayne Pharma has ...
read more
Mayne Pharma Group Limited, a publicly held company based in Melbourne, Australia, is pleased to announce that it has entered into a binding agreement to acquire Metrics, Inc., a privately-owned provider of contract development services to the ...
read more
Mayne Pharma is pleased to announce that it has entered into a binding agreement to acquire a portfolio of U.S. generic products from Teva and Allergan for cash consideration of $652 million.
read more
Mayne Pharma has entered into a binding agreement to acquire a portfolio of U.S. generic products from Teva and Allergan for cash consideration of $652 million. The portfolio consists of 37 approved products and 5 FDA filed products in attractive ...
read more